0

    543828

    SUDARSHAN

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    SUDARSHAN PHARMA INDUSTRIES LI Share Price Today

    Investment Returns

    Over 1 Month -15.56% Over 3 Months 13.29% Over 6 Months 29.37% Over 1 Year 10.21%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    SUDARSHAN PHARMA INDUSTRIES LI fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 777.30
    • P/E Ratio (TTM) 37.36
    • Beta 0.60
    • Book Value / share 6.34
    • Return on equity 14.79%
    • EPS (TTM) 0.91
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 9.54
    info icon alternate text

    SUDARSHAN PHARMA INDUSTRIES LI Financials

    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 199.81
    Operating Expense 189.78
    Net Profit 9.54
    Net Profit Margin (%) 4.77
    Earnings Per Share (EPS) 0.40
    EBITDA 21.50
    Effective Tax Rate (%) 27.89
    Particulars DEC 2025 (Values in Cr)
    Revenue 158.37
    Operating Expense 154.64
    Net Profit 4.31
    Net Profit Margin (%) 2.72
    Earnings Per Share (EPS) 0.18
    EBITDA 12.47
    Effective Tax Rate (%) 20.47
    Particulars SEP 2025 (Values in Cr)
    Revenue 167.01
    Operating Expense 164.26
    Net Profit 4.40
    Net Profit Margin (%) 2.63
    Earnings Per Share (EPS) 0.18
    EBITDA 11.71
    Effective Tax Rate (%) 8.69
    Particulars JUN 2025 (Values in Cr)
    Revenue 142.31
    Operating Expense 138.53
    Net Profit 3.73
    Net Profit Margin (%) 2.62
    Earnings Per Share (EPS) 0.15
    EBITDA 11.69
    Effective Tax Rate (%) 28.13
    Particulars MAR 2025 (Values in Cr)
    Revenue 161.57
    Operating Expense 151.55
    Net Profit 7.03
    Net Profit Margin (%) 4.35
    Earnings Per Share (EPS) 0.29
    EBITDA 14.47
    Effective Tax Rate (%) 24.27
    Particulars MAR 2026 (Values in Cr)
    Revenue 667.50
    Operating Expense 647.24
    Net Profit 21.98
    Net Profit Margin (%) 3.29
    Earnings Per Share (EPS) 0.91
    EBITDA 57.37
    Effective Tax Rate (%) 23.33
    Particulars MAR 2025 (Values in Cr)
    Revenue 502.49
    Operating Expense 483.87
    Net Profit 14.02
    Net Profit Margin (%) 2.79
    Earnings Per Share (EPS) 0.58
    EBITDA 37.73
    Effective Tax Rate (%) 25.41
    Particulars MAR 2024 (Values in Cr)
    Revenue 465.56
    Operating Expense 453.21
    Net Profit 11.36
    Net Profit Margin (%) 2.44
    Earnings Per Share (EPS) 4.72
    EBITDA 25.36
    Effective Tax Rate (%) 24.76
    Particulars MAR 2023 (Values in Cr)
    Revenue 461.33
    Operating Expense 452.95
    Net Profit 7.04
    Net Profit Margin (%) 1.52
    Earnings Per Share (EPS) 5.46
    EBITDA 15.81
    Effective Tax Rate (%) 25.89
    Particulars MAR 2022 (Values in Cr)
    Revenue 357.09
    Operating Expense 350.42
    Net Profit 5.25
    Net Profit Margin (%) 1.47
    Earnings Per Share (EPS) 5.46
    EBITDA 11.38
    Effective Tax Rate (%) 26.47
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 5.30
    ROE % 14.82
    ROCE % 15.48
    Total Debt to Total Equity 1.13
    EBITDA Margin 8.40
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 46.42
    ROE % 10.78
    ROCE % 13.74
    Total Debt to Total Equity 0.65
    EBITDA Margin 5.48
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 41.96
    ROE % 10.77
    ROCE % 15.24
    Total Debt to Total Equity 0.49
    EBITDA Margin 3.42
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 30.54
    ROE % 20.08
    ROCE % 18.67
    Total Debt to Total Equity 1.15
    EBITDA Margin 3.19
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 23.58
    ROE % 12.61
    ROCE % 14.63
    Total Debt to Total Equity 1.19
    EBITDA Margin 3.90
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 5.30
    ROE % 14.79
    ROCE % 15.30
    Total Debt to Total Equity 1.15
    EBITDA Margin 8.23
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 46.38
    ROE % 10.69
    ROCE % 13.63
    Total Debt to Total Equity 0.66
    EBITDA Margin 5.45
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 41.96
    ROE % 10.77
    ROCE % 15.24
    Total Debt to Total Equity 0.49
    EBITDA Margin 3.43
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 30.55
    ROE % 20.08
    ROCE % 18.67
    Total Debt to Total Equity 1.15
    EBITDA Margin 3.19
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 23.58
    ROE % 12.61
    ROCE % 14.63
    Total Debt to Total Equity 1.19
    EBITDA Margin 3.90
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.55
    Total Assets 402.40
    Total Liabilities 402.40
    Total Equity 131.48
    Share Outstanding 24
    Price to Book Ratio 5.76
    Return on Assets (%) 3.96
    Return on Capital (%) 5.28
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.14
    Total Assets 283.12
    Total Liabilities 283.12
    Total Equity 111.70
    Share Outstanding 2
    Price to Book Ratio 1.60
    Return on Assets (%) 4.04
    Return on Capital (%) 5.29
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 11.71
    Total Assets 232.47
    Total Liabilities 232.47
    Total Equity 100.97
    Share Outstanding 2
    Price to Book Ratio 1.33
    Return on Assets (%) 3.02
    Return on Capital (%) 5.21
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.23
    Total Assets 137.52
    Total Liabilities 137.52
    Total Equity 29.77
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 3.81
    Return on Capital (%) 8.69
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 1.25
    Total Assets 99.26
    Total Liabilities 99.26
    Total Equity 22.55
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 2.69
    Return on Capital (%) 5.42
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.38
    Total Assets 400.39
    Total Liabilities 400.39
    Total Equity 131.31
    Share Outstanding 24
    Price to Book Ratio 5.76
    Return on Assets (%) 3.96
    Return on Capital (%) 5.22
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.13
    Total Assets 284.84
    Total Liabilities 284.84
    Total Equity 111.61
    Share Outstanding 2
    Price to Book Ratio 1.60
    Return on Assets (%) 3.98
    Return on Capital (%) 5.2
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 11.71
    Total Assets 232.46
    Total Liabilities 232.46
    Total Equity 100.98
    Share Outstanding 2
    Price to Book Ratio 1.33
    Return on Assets (%) 3.02
    Return on Capital (%) 5.21
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.22
    Total Assets 137.51
    Total Liabilities 137.51
    Total Equity 29.78
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 3.81
    Return on Capital (%) 8.7
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 1.15
    Total Assets 99.21
    Total Liabilities 99.21
    Total Equity 22.50
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 2.69
    Return on Capital (%) 5.11
    Particulars MAR 2025 (Values in Cr)
    Net Income 21.62
    Cash from Operations 38.16
    Cash from Investing -20.40
    Cash from Financing -14.44
    Net change in Cash 0.36
    Free Cash Flow 38.74
    Particulars MAR 2024 (Values in Cr)
    Net Income 15.22
    Cash from Operations 8.16
    Cash from Investing -5.49
    Cash from Financing -12.09
    Net change in Cash -11.57
    Free Cash Flow 10.08
    Particulars MAR 2023 (Values in Cr)
    Net Income 9.49
    Cash from Operations -26.68
    Cash from Investing -25.65
    Cash from Financing 65.92
    Net change in Cash 11.48
    Free Cash Flow -12.36
    Particulars MAR 2022 (Values in Cr)
    Net Income 7.13
    Cash from Operations -2.05
    Cash from Investing -1.45
    Cash from Financing 4.26
    Net change in Cash -1.01
    Free Cash Flow -0.93
    Particulars MAR 2021 (Values in Cr)
    Net Income 3.57
    Cash from Operations 3.60
    Cash from Investing -1.29
    Cash from Financing -1.48
    Net change in Cash -0.01
    Free Cash Flow 4.92
    Particulars MAR 2025 (Values in Cr)
    Net Income 21.28
    Cash from Operations 37.74
    Cash from Investing -20.24
    Cash from Financing -14.40
    Net change in Cash 0.25
    Free Cash Flow 38.27
    Particulars MAR 2024 (Values in Cr)
    Net Income 15.09
    Cash from Operations 11.80
    Cash from Investing -9.08
    Cash from Financing -12.18
    Net change in Cash -11.57
    Free Cash Flow 13.72
    Particulars MAR 2023 (Values in Cr)
    Net Income 9.49
    Cash from Operations -26.68
    Cash from Investing -25.65
    Cash from Financing 65.92
    Net change in Cash 11.48
    Free Cash Flow -12.35
    Particulars MAR 2022 (Values in Cr)
    Net Income 7.13
    Cash from Operations -1.93
    Cash from Investing -1.53
    Cash from Financing 4.30
    Net change in Cash -0.92
    Free Cash Flow -0.81
    Particulars MAR 2021 (Values in Cr)
    Net Income 3.57
    Cash from Operations 3.71
    Cash from Investing -1.34
    Cash from Financing -1.63
    Net change in Cash -0.11
    Free Cash Flow 5.03
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    ATUL LTD. 6768.40 25.05 3.20 19927.36 5563.00 7198.20
    BASF INDIA LTD. 4088.65 28.68 4.47 17697.98 2906.90 4821.00
    ORIENTAL AROMATICS LTD 379.85 240.41 1.92 1278.33 227.05 403.85
    DEEPAK FERTILISERS & PETROCHEM 1537.95 19.73 2.83 19414.75 865.45 1681.25
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    ADVANCE PETROCHEMICALS LTD. 156.00 472.73 3.53 14.04 97.60 320.75
    ATUL LTD. 6768.40 28.54 3.29 19927.36 5563.00 7198.20
    BASF INDIA LTD. 4088.65 28.58 4.44 17697.98 2906.90 4821.00
    ORIENTAL AROMATICS LTD 379.85 46.15 1.82 1278.33 227.05 403.85

    SUDARSHAN PHARMA INDUSTRIES LI shareholding pattern

    Holding
    21.69%
    58.92%
    19.38%
    1.36%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    SUDARSHAN PHARMA INDUSTRIES LI Technicals Summary

    32.30 -5.00 redarrow
    red-green-graph indicator
    14 Bearish
    2 Bullish
    • 5 Days 34.60
    • 26 Days 37.70
    • 10 Days 36.10
    • 50 Days 37.00
    • 12 Days 36.60
    • 100 Days 34.50
    • 20 Days 37.50
    • 200 Days 32.00
    33.59 PIVOT
    First Support 32.71 First Resistance 34.89 Second Support 31.41 Second Resistance 35.77 Third Support 30.53 Third Resistance 37.07
    RSI 36.50 ADX 22.94 MACD -1.17 Williams % R -73.74 Commodity Channel Index (CCI) -144.63
    Date 2026-08-07 Week 512000.00 Same Day 984000.00 Month 434667.00
    1 Year 0.61 3 Year 0.57
    Over 1 Month
    -15.56% down
    Over 1 Year
    10.21% down
    Over 3 Months
    13.29% down
    Over 3 Years
    66.77% down
    Over 6 Months
    29.37% down
    Over 5 Years
    0.00% down

    SUDARSHAN PHARMA INDUSTRIES LI Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    25 Aug 2023 0.3 Final 26 Aug 2023 Equity shares
    Ex-Date Old FV NEW FV Record Date
    22 Nov 2024 10.0 1.0 23 Nov 2024

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Sudarshan Pharma Industries Ltd?

    Answer Field

    Sudarshan Pharma Industries Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 32.30 as on Aug 10 2026 03:27 PM.

    What is the Market Cap of Sudarshan Pharma Industries Ltd Share?

    Answer Field

    The market cap of Sudarshan Pharma Industries Ltd for NSE ₹ 0.00 & for BSE ₹ 777.30 as on Aug 10 2026 03:27 PM.

    What is the 52 Week High and Low of Sudarshan Pharma Industries Ltd?

    Answer Field

    The 52 Week High and Low of Sudarshan Pharma Industries Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 42.79 and ₹ 18.50.

    What is 1 year return for Sudarshan Pharma Industries Ltd?

    Answer Field

    The 1 year returns on the stock has been 10.21%.

    What is the P/E Ratio of Sudarshan Pharma Industries Ltd Share?

    Answer Field

    As on Aug 10 2026 03:27 PM the price-to-earnings (PE) ratio for Sudarshan Pharma Industries Ltd share is 37.36.

    What is the PB ratio of Sudarshan Pharma Industries Ltd Share?

    Answer Field

    As on Aug 10 2026 03:27 PM, the price-to-book (PB) ratio for Sudarshan Pharma Industries Ltd share is 6.34.

    How to Buy Sudarshan Pharma Industries Ltd Share?

    Answer Field

    You can trade in Sudarshan Pharma Industries Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Sudarshan Pharma Industries Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Sudarshan Pharma Industries Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Sudarshan Pharma Industries Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |